181 related articles for article (PubMed ID: 28648520)
1. PKMYT1 promoted the growth and motility of hepatocellular carcinoma cells by activating beta-catenin/TCF signaling.
Liu L; Wu J; Wang S; Luo X; Du Y; Huang D; Gu D; Zhang F
Exp Cell Res; 2017 Sep; 358(2):209-216. PubMed ID: 28648520
[TBL] [Abstract][Full Text] [Related]
2. DIAPH3 promoted the growth, migration and metastasis of hepatocellular carcinoma cells by activating beta-catenin/TCF signaling.
Dong L; Li Z; Xue L; Li G; Zhang C; Cai Z; Li H; Guo R
Mol Cell Biochem; 2018 Jan; 438(1-2):183-190. PubMed ID: 28795316
[TBL] [Abstract][Full Text] [Related]
3. CDK7 activated beta-catenin/TCF signaling in hepatocellular carcinoma.
Duan J; He Y; Fu X; Deng Y; Zheng M; Lu D
Exp Cell Res; 2018 Sep; 370(2):461-467. PubMed ID: 29981747
[TBL] [Abstract][Full Text] [Related]
4. CARF activates beta-catenin/TCF signaling in the hepatocellular carcinoma.
Fan X; Ma X; Cui L; Dang S; Qu J; Zhang J; Wang X; Mao Z
Oncotarget; 2016 Dec; 7(49):80404-80414. PubMed ID: 27829235
[TBL] [Abstract][Full Text] [Related]
5. STIP1 is over-expressed in hepatocellular carcinoma and promotes the growth and migration of cancer cells.
Luo X; Liu Y; Ma S; Liu L; Xie R; Li M; Shen P; Wang S
Gene; 2018 Jul; 662():110-117. PubMed ID: 29596884
[TBL] [Abstract][Full Text] [Related]
6. TM4SF1, a binding protein of DVL2 in hepatocellular carcinoma, positively regulates beta-catenin/TCF signalling.
Zhu C; Luo X; Wu J; Liu Y; Liu L; Ma S; Xie R; Wang S; Ji W
J Cell Mol Med; 2021 Mar; 25(5):2356-2364. PubMed ID: 31876386
[TBL] [Abstract][Full Text] [Related]
7. Spermidine/spermine N1-acetyltransferase regulates cell growth and metastasis via AKT/β-catenin signaling pathways in hepatocellular and colorectal carcinoma cells.
Wang C; Ruan P; Zhao Y; Li X; Wang J; Wu X; Liu T; Wang S; Hou J; Li W; Li Q; Li J; Dai F; Fang D; Wang C; Xie S
Oncotarget; 2017 Jan; 8(1):1092-1109. PubMed ID: 27901475
[TBL] [Abstract][Full Text] [Related]
8. Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma.
Yamashita T; Budhu A; Forgues M; Wang XW
Cancer Res; 2007 Nov; 67(22):10831-9. PubMed ID: 18006828
[TBL] [Abstract][Full Text] [Related]
9. Liver cancer: WISP3 suppresses hepatocellular carcinoma progression by negative regulation of β-catenin/TCF/LEF signalling.
Gao H; Yin FF; Guan DX; Feng YX; Zheng QW; Wang X; Zhu M; Zhang XL; Cheng SQ; Chen TW; Jiang H; Zhang EB; Wang JJ; Ni QZ; Yuan YM; Zhang FK; Ma N; Cao HJ; Wang YK; Li JJ; Xie D
Cell Prolif; 2019 May; 52(3):e12583. PubMed ID: 30793395
[TBL] [Abstract][Full Text] [Related]
10. FGF19 promotes epithelial-mesenchymal transition in hepatocellular carcinoma cells by modulating the GSK3β/β- catenin signaling cascade via FGFR4 activation.
Zhao H; Lv F; Liang G; Huang X; Wu G; Zhang W; Yu L; Shi L; Teng Y
Oncotarget; 2016 Mar; 7(12):13575-86. PubMed ID: 26498355
[TBL] [Abstract][Full Text] [Related]
11. PKM2 regulates hepatocellular carcinoma cell epithelial-mesenchymal transition and migration upon EGFR activation.
Fan FT; Shen CS; Tao L; Tian C; Liu ZG; Zhu ZJ; Liu YP; Pei CS; Wu HY; Zhang L; Wang AY; Zheng SZ; Huang SL; Lu Y
Asian Pac J Cancer Prev; 2014; 15(5):1961-70. PubMed ID: 24716919
[TBL] [Abstract][Full Text] [Related]
12. KDM2B mediates the Wnt/β-catenin pathway through transcriptional activation of PKMYT1 via microRNA-let-7b-5p/EZH2 to affect the development of non-small cell lung cancer.
Zhang X; Yin Z; Li C; Nie L; Chen K
Exp Cell Res; 2022 Aug; 417(2):113208. PubMed ID: 35580699
[TBL] [Abstract][Full Text] [Related]
13. A double-negative feedback loop between Wnt-β-catenin signaling and HNF4α regulates epithelial-mesenchymal transition in hepatocellular carcinoma.
Yang M; Li SN; Anjum KM; Gui LX; Zhu SS; Liu J; Chen JK; Liu QF; Ye GD; Wang WJ; Wu JF; Cai WY; Sun GB; Liu YJ; Liu RF; Zhang ZM; Li BA
J Cell Sci; 2013 Dec; 126(Pt 24):5692-703. PubMed ID: 24101726
[TBL] [Abstract][Full Text] [Related]
14. YEATS4 promotes the tumorigenesis of pancreatic cancer by activating beta-catenin/TCF signaling.
Jixiang C; Shengchun D; Jianguo Q; Zhengfa M; Xin F; Xuqing W; Jianxin Z; Lei C
Oncotarget; 2017 Apr; 8(15):25200-25210. PubMed ID: 28445953
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of LRP1B in colon cancer promoted the growth and migration of cancer cells.
Wang Z; Sun P; Gao C; Chen J; Li J; Chen Z; Xu M; Shao J; Zhang Y; Xie J
Exp Cell Res; 2017 Aug; 357(1):1-8. PubMed ID: 28408316
[TBL] [Abstract][Full Text] [Related]
16. The transcription factor 7 like 2‑binding protein TIP5 activates β‑catenin/transcription factor signaling in hepatocellular carcinoma.
Li C; Wu W; Ding H; Li Q; Xie K
Mol Med Rep; 2018 Jun; 17(6):7645-7651. PubMed ID: 29620186
[TBL] [Abstract][Full Text] [Related]
17. Serum and glucocorticoid kinase 1 promoted the growth and migration of non-small cell lung cancer cells.
Xiaobo Y; Qiang L; Xiong Q; Zheng R; Jianhua Z; Zhifeng L; Yijiang S; Zheng J
Gene; 2016 Jan; 576(1 Pt 2):339-46. PubMed ID: 26548813
[TBL] [Abstract][Full Text] [Related]
18. The TTYH3/MK5 Positive Feedback Loop regulates Tumor Progression via GSK3-β/β-catenin signaling in HCC.
Wang Y; Xie Y; Dong B; Xue W; Chen S; Mitsuo S; Zou H; Feng Y; Ma K; Dong Q; Cao J; Zhu C
Int J Biol Sci; 2022; 18(10):4053-4070. PubMed ID: 35844789
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase, membrane‑associated tyrosine/threonine 1 is associated with the progression of colorectal cancer.
Jeong D; Kim H; Kim D; Ban S; Oh S; Ji S; Kang D; Lee H; Ahn TS; Kim HJ; Bae SB; Lee MS; Kim CJ; Kwon HY; Baek MJ
Oncol Rep; 2018 Jun; 39(6):2829-2836. PubMed ID: 29658598
[TBL] [Abstract][Full Text] [Related]
20. Incomplete radiofrequency ablation enhances invasiveness and metastasis of residual cancer of hepatocellular carcinoma cell HCCLM3 via activating β-catenin signaling.
Zhang N; Wang L; Chai ZT; Zhu ZM; Zhu XD; Ma DN; Zhang QB; Zhao YM; Wang M; Ao JY; Ren ZG; Gao DM; Sun HC; Tang ZY
PLoS One; 2014; 9(12):e115949. PubMed ID: 25542041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
